Carbidopa and Levodopa
- Product NDC
- 0615-8461
- 11-digit product format
- 006158461
- Labeler code
- 0615
- Product ID
- 0615-8461_bd08f206-2051-4ac7-b4ac-b0b83a79029d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbidopa and Levodopa
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA214091
- Marketing category
- ANDA
- Marketing start
- 2021-10-05
- Substance
- CARBIDOPA; LEVODOPA
- Active strength
- 50; 200 mg/1; mg/1
- Pharmacologic classes
- Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| MNX7R8C5VO | CARBIDOPA | 38821-49-7 | CARBIDOPA |
| 46627O600J | LEVODOPA | 59-92-7 | LEVODOPA |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0615-8461-39 | 00615846139 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8461-39) | 2023-04-03 | No | No | Historical |